- Home
- QURE vs PJT Comparison
QURE vs PJT Comparison
Compare QURE & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- PJT
- Stock Information
- Founded
- QURE 1998
- PJT 2014
- Country
- QURE Netherlands
- PJT United States
- Employees
- QURE N/A
- PJT N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- PJT Investment Managers
- Sector
- QURE Health Care
- PJT Finance
- Exchange
- QURE Nasdaq
- PJT Nasdaq
- Market Cap
- QURE 4.3B
- PJT 3.9B
- IPO Year
- QURE 2007
- PJT N/A
- Fundamental
- Price
- QURE $30.76
- PJT $158.35
- Analyst Decision
- QURE Strong Buy
- PJT Hold
- Analyst Count
- QURE 13
- PJT 3
- Target Price
- QURE $62.33
- PJT $193.50
- AVG Volume (30 Days)
- QURE 4.6M
- PJT 238.2K
- Earning Date
- QURE 11-10-2025
- PJT 11-04-2025
- Dividend Yield
- QURE N/A
- PJT 0.63%
- EPS Growth
- QURE N/A
- PJT 72.84
- EPS
- QURE N/A
- PJT 6.53
- Revenue
- QURE $15,751,000.00
- PJT $1,657,789,000.00
- Revenue This Year
- QURE N/A
- PJT $11.42
- Revenue Next Year
- QURE $229.18
- PJT $12.18
- P/E Ratio
- QURE N/A
- PJT $24.31
- Revenue Growth
- QURE N/A
- PJT 23.30
- 52 Week Low
- QURE $5.50
- PJT $119.76
- 52 Week High
- QURE $71.50
- PJT $190.28
- Technical
- Relative Strength Index (RSI)
- QURE 36.57
- PJT 33.85
- Support Level
- QURE $25.24
- PJT $166.52
- Resistance Level
- QURE $31.16
- PJT $172.97
- Average True Range (ATR)
- QURE 3.74
- PJT 6.47
- MACD
- QURE -2.28
- PJT -0.46
- Stochastic Oscillator
- QURE 16.43
- PJT 2.93
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About PJT PJT Partners Inc.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.